Gynecologic Oncology is a specialized field of medicine that focuses on cancers of the female reproductive system including ovarian, uterine / endometrial, cervical, vulvar and other female genital cancers. Gynecologic cancer is the fourth most common type of cancer in women, affecting approximately 1 in 20 women. In the United States each year, approximately 80,000 women are diagnosed with a gynecologic cancer.
The University of Tennessee Medical Center offers women access to an entire team of cancer specialists focused on the care of gynecologic cancers led by board certified gynecologic oncologist, Larry C. Kilgore, MD. Women have access to advanced diagnostic and treatment options including surgery, chemotherapy, radiation therapy and clinical trials for the management of gynecologic cancers. Surgical options include traditional procedures as well as advanced minimally invasive robotic surgery with the da Vinci Surgical System. No matter the type of procedure, the gynecologic oncologists at the medical center have the necessary knowledge and skills for optimal surgical outcomes.
Gynecologic oncologists also manage the administration of chemotherapy and provide continuity of care for their patients. At the medical center, cutting-edge treatment is offered to patients along with opportunities to participate in National Cancer Institute and pharmaceutical clinical trials. Intraperitoneal chemotherapy is available and utilized for appropriate patients to provide the best possible outcome. The gynecologic oncologists also collaborate with radiation oncologists to provide advanced radiation therapy including external beam radiation and high dose rate (HDR) brachytherapy.